3,4-MD-PCP: NMDA receptor affinity approximately 62 nM, placing potency between 3-MeO-PCP and ketamine. Users describe warm, chameleonic dissociation that varies dramatically with dose and setting, ranging from lucid sociability at low doses to overwhelming mania at high doses. The dose-response cur
Related pages